Medical Journals

Constitutive Expression of B7-1 on B Cells Uncovers Autoimmunity Toward the B Cell Compartment in the Nonobese Diabetic Mouse.

Authors:
  • Bour-Jordan Hélène
  • Salomon Benoit L
  • Thompson Heather L
  • Santos Rex
  • Abbas Abul K
  • Bluestone Jeffrey A

From: University of California, San Francisco Diabetes Center, Department of Medicine, CA 94143, USA.

Journal of immunology (Baltimore, Md. : 1950)

  • Publish Date: Jul 2007
  • ISSN: 0022-1767
  • Volume: 179
  • Issue: 2
  • Pages: 1004-12
  • Medium: Print
  • Language: English
  • Citation (JAMA): Bour-Jordan Hélène, Salomon Benoit L, Thompson Heather L, et al. Constitutive Expression of B7-1 on B Cells Uncovers Autoimmunity Toward the B Cell Compartment in the Nonobese Diabetic Mouse.. J. Immunol. Jul 2007;179:1004-12

Abstract

The NOD mouse is an invaluable model for the study of autoimmune diabetes. Furthermore, although less appreciated, NOD mice are susceptible to other autoimmune diseases that can be differentially manifested by altering the balance of T cell costimulatory pathways. In this study, we show that constitutively expressing B7-1 on B cells (NOD-B7-1B-transgenic mice) resulted in reduced insulitis and completely protected NOD mice from developing diabetes. Furthermore, B7-1 expression led to a dramatic reduction of the B cell compartment due to a selective deletion of follicular B cells in the spleen, whereas marginal zone B cells were largely unaffected. B cell depletion was dependent on B cell specificity, mediated by CD8(+) T cells, and occurred exclusively in the autoimmune-prone NOD background. Our results suggest that B cell deletion was a consequence of the specific activation of autoreactive T cells directed at peripheral self Ags presented by maturing B cells that expressed B7-1 costimulatory molecules. This study underscores the importance of B7 costimulatory molecules in controlling the amplitude and target of autoimmunity in genetically prone individuals and has important implications in the use of costimulatory pathway antagonists in the treatment of human autoimmune diseases.

Mesh Headings (Keywords): Adoptive Transfer, Animals, Antigens, CD28, Antigens, CD80, Autoantigens, Autoimmunity, B-Lymphocytes, Diabetes Mellitus, Type 1, Flow Cytometry, Mice, Mice, Inbred NOD, Mice, Transgenic, Spleen, T-Lymphocytes


Check for Full Text / PubMed Unique Identifier (PMID): 17617592


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.